Cargando…

Preformulation Characterization and Stability Assessments of Secretory IgA Monoclonal Antibodies as Potential Candidates for Passive Immunization by Oral Administration

Enterotoxigenic Escherichia coli (ETEC) is a major cause of diarrheal disease among children in developing countries, and there are no licensed vaccines to protect against ETEC. Passive immunization by oral delivery of ETEC-specific secretory IgAs (sIgAs) could potentially provide an alternative app...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hu, Yue, Kumru, Ozan S., Xiong, Jian, Antunez, Lorena R., Hickey, John, Wang, Yang, Cavacini, Lisa, Klempner, Mark, Joshi, Sangeeta B., Volkin, David B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6941217/ https://www.ncbi.nlm.nih.gov/pubmed/31369743 http://dx.doi.org/10.1016/j.xphs.2019.07.018

Ejemplares similares

Investigation of a monoclonal antibody against enterotoxigenic Escherichia coli, expressed as secretory IgA1 and IgA2 in plants
por: Teh, Audrey Y-H, et al.
Publicado: (2021)

IgA as a potential candidate for enteric monoclonal antibody therapeutics with improved gastrointestinal stability
por: Wallace, Aaron L., et al.
Publicado: (2020)

Coformulation of Broadly Neutralizing Antibodies 3BNC117 and PGT121: Analytical Challenges During Preformulation Characterization and Storage Stability Studies
por: Patel, Ashaben, et al.
Publicado: (2018)

Correlating physicochemical and biological properties to define critical quality attributes of a rAAV vaccine candidate
por: Kumar, Prashant, et al.
Publicado: (2023)

Stabilization and formulation of a recombinant Human Cytomegalovirus vector for use as a candidate HIV-1 vaccine
por: Kumru, Ozan S., et al.
Publicado: (2019)

Preformulation Characterization of Griffithsin, a Biopharmaceutical Candidate for HIV Prevention
por: Kramzer, Lindsay F., et al.
Publicado: (2021)

Preformulation Studies on Piperlongumine
por: Aodah, Alhassan, et al.
Publicado: (2016)

Impact of IgA constant domain on HIV-1 neutralizing function of monoclonal antibody F425-A1g8
por: Yu, X, et al.
Publicado: (2012)

Formulation development and comparability studies with an aluminum-salt adjuvanted SARS-CoV-2 Spike ferritin nanoparticle vaccine antigen produced from two different cell lines
por: Kumru, Ozan S., et al.
Publicado: (2023)

Mechanism of neutralization of influenza virus by secretory IgA is different from that of monomeric IgA or IgG
Publicado: (1985)

Secretory IgA: Designed for Anti-Microbial Defense
por: Brandtzaeg, Per
Publicado: (2013)

The Effects of Secretory IgA in the Mucosal Immune System
por: Li, Yue, et al.
Publicado: (2020)

The prospect of orally administered monoclonal secretory IgA (SIgA) antibodies to prevent enteric bacterial infections
por: Richards, Angelene, et al.
Publicado: (2021)

Effect of Formulation Variables on the Stability of a Live, Rotavirus (RV3-BB) Vaccine Candidate using in vitro Gastric Digestion Models to Mimic Oral Delivery
por: Kumar, Prashant, et al.
Publicado: (2021)

Secretory component as the receptor for polymeric IgA on rat hepatocytes
Publicado: (1979)

Identification of secretory component as an IgA receptor on rat hepatocytes
Publicado: (1979)

Multi-Faceted Functions of Secretory IgA at Mucosal Surfaces
por: Corthésy, Blaise
Publicado: (2013)

Secretory IgA impacts the microbiota density in the human nose
por: van Dalen, Rob, et al.
Publicado: (2023)

Monoclonal IgA Antibodies for Aflatoxin Immunoassays
por: Ertekin, Özlem, et al.
Publicado: (2016)

Formulation development of a live attenuated human rotavirus (RV3-BB) vaccine candidate for use in low- and middle-income countries
por: Kumar, Prashant, et al.
Publicado: (2021)

A cross-reactive human IgA monoclonal antibody blocks SARS-CoV-2 spike-ACE2 interaction
por: Ejemel, Monir, et al.
Publicado: (2020)

KM55 Monoclonal Antibody and IgA Variant of Proliferative Glomerulonephritis With Monoclonal Ig Deposits
por: Zhang, Minfang, et al.
Publicado: (2020)

Oral Passive Immunization With Plasma-Derived Polyreactive Secretory-Like IgA/M Partially Protects Mice Against Experimental Salmonellosis
por: Corthésy, Blaise, et al.
Publicado: (2018)

IgA nephropathy to proliferative glomerulonephritis with monoclonal IgAκ deposits: a pattern switch
por: Li, Jin-pu, et al.
Publicado: (2023)

Systemic administration of an HIV 1 broadly neutralizing dimeric IgA yields mucosal secretory IgA and virus neutralization
por: Fouda, Genevieve G., et al.
Publicado: (2016)

High levels of secretory IgA and free secretory component in the serum of rats with bile duct obstruction
Publicado: (1978)

Galactose-Deficient IgA1 as a Candidate Urinary Marker of IgA Nephropathy
por: Fukao, Yusuke, et al.
Publicado: (2022)

Changes in fucosylation of human seminal IgG and secretory component of IgA in leukocytospermic patients
por: Kratz, Ewa M., et al.
Publicado: (2013)

Passive Immunity to Vibrio cholerae O1 Afforded by a Human Monoclonal IgA1 Antibody Expressed in Milk
por: Baranova, Danielle E., et al.
Publicado: (2020)

A C-terminal Pfs48/45 malaria transmission-blocking vaccine candidate produced in the baculovirus expression system
por: Lee, Shwu-Maan, et al.
Publicado: (2020)

Galactose-Deficient IgA1 as a Candidate Urinary Polypeptide Marker of IgA Nephropathy?
por: Suzuki, Hitoshi, et al.
Publicado: (2016)

On psychobiology in psychoanalysis - salivary cortisol and secretory IgA as psychoanalytic process parameters
por: Euler, Sebastian, et al.
Publicado: (2005)

Host Immune Selection of Rumen Bacteria through Salivary Secretory IgA
por: Fouhse, Janelle M., et al.
Publicado: (2017)

Enhanced SARS-CoV-2 Neutralization by Secretory IgA in vitro
por: Wang, Zijun, et al.
Publicado: (2020)

Characterizing and Minimizing Aggregation and Particle Formation of Three Recombinant Fusion-Protein Bulk Antigens for Use in a Candidate Trivalent Rotavirus Vaccine
por: Agarwal, Sanjeev, et al.
Publicado: (2020)

Development of a candidate stabilizing formulation for bulk storage of a double mutant heat labile toxin (dmLT) protein based adjuvant
por: Toprani, Vishal M., et al.
Publicado: (2017)

IgA Nephropathy in a Patient with IgG Myeloma
por: Lakshmi, B. Sangeeta, et al.
Publicado: (2018)

Crystallization of a nonreplicating rotavirus vaccine candidate
por: Hong, Moo Sun, et al.
Publicado: (2021)

LOCALIZATION OF FREE AND BOUND SECRETORY COMPONENT IN HUMAN INTESTINAL EPITHELIAL CELLS : A MODEL FOR THE ASSEMBLY OF SECRETORY IgA
por: Poger, Marshall E., et al.
Publicado: (1974)

Inhibition of invasive salmonella by orally administered IgA and IgG monoclonal antibodies
por: Richards, Angelene F., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_cn0kfa8h75va5v21vgqvo18rfh